Page last updated: 2024-12-05

phenylbenzoquinone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

phenylbenzoquinone: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9688
CHEMBL ID274117
SCHEMBL ID26262
MeSH IDM0093583

Synonyms (49)

Synonym
phenyl-1,4-benzoquinone
2-phenyl-p-benzoquinone
nsc-2806
nsc2806
wln: l6v dvj xr
p-benzoquinone, phenyl-
2-phenyl-1,4-benzoquinone
363-03-1
2,4-dione, 2-phenyl-
p-benzoquinone, 2-phenyl-
2-phenylbenzoquinone
phenyl-p-benzoquinone
phenylquinone
2,5-cyclohexadiene-1,4-dione, 2-phenyl-
nsc 2806
einecs 206-654-5
ccris 4280
2-phenyl-2,5-cyclohexadiene-1,4-dione
o-phenylbenzoquinone
phenylbenzoquinone
2-phenyl-1,4-benzoquinone, 10
2-phenylcyclohexa-2,5-diene-1,4-dione
phenyl-p-benzoquinone, 5
bdbm24781
phenyl-p-quinone
CHEMBL274117
2-phenyl-[1,4]benzoquinone
AKOS002663214
unii-knb6553j7r
knb6553j7r ,
[1,1'-biphenyl]-2,5-dione
SCHEMBL26262
DTXSID3059892
2-phenylquinone
2-phenylbenzo-1,4-quinone #
phenyl-1,4-benzoquinone, 2-
quinone, phenyl-
2-phenylbenzo-1,4-quinone
phenyl p-benzoquinone
Q27889390
tfiih modulator-19
mfcd00001599
tfiih modulator19
AMY38645
A874378
CS-0320213
F87890
P2674
PD137256

Research Excerpts

Actions

ExcerptReferenceRelevance
"phenylbenzoquinone, PBQ) increase the threshold for vocalization to tail-shock."( Morphine antagonizes inhibitory controls of nociceptive reactions, triggered by visceral pain in the rat.
Kraus, E; Le Bars, D, 1986
)
0.99

Toxicity

ExcerptReferenceRelevance
" Since the 3-phenylquinolone derivative 1b suffered from toxicity issues toward human macrophages, herein we report a two-pronged medicinal chemistry workflow for identifying new potent and safe NTM EPIs."( Modifications on C6 and C7 Positions of 3-Phenylquinolone Efflux Pump Inhibitors Led to Potent and Safe Antimycobacterial Treatment Adjuvants.
Astolfi, A; Barreca, ML; Cannalire, R; Cecchetti, V; Felicetti, T; Machado, D; Manfroni, G; Massari, S; Sabatini, S; Tabarrini, O; Viveiros, M, 2019
)
0.51

Bioavailability

ExcerptReferenceRelevance
" Bioavailability and pharmacokinetics tests after oral and intravenous administration suggest that morniflumate is absorbed as such from the gastrointestinal tract and then undergoes rapid hydrolysis in the plasma, releasing the free acidic form, the molecule responsible for the pharmacological effects."( A gastroprotective anti-inflammatory agent: the beta-morpholinoethyl ester of niflumic acid (morniflumate).
Acerbi, D; Cadel, S; Schiantarelli, P, 1984
)
0.27
" Bioavailability studies show that conversion to piroxicam is about 100%, 90%, 70%, and 50% in these four species, respectively."( Ampiroxicam, an anti-inflammatory agent which is a prodrug of piroxicam.
Carty, TJ; Falkner, FC; Marfat, A; Moore, PF; Twomey, TM; Weissman, A, 1993
)
0.29
" In humans, the relative bioavailability of oral dexketoprofen trometamol (12."( Preclinical and clinical development of dexketoprofen.
Artigas, R; Carganico, G; García, ML; Mauleón, D, 1996
)
0.29

Dosage Studied

ExcerptRelevanceReference
"26X + 535, where Y is the projected human daily dosage (mg)."( Prediction of human analgesic dosages of nonsteroidal anti-inflammatory drugs (NSAIDs) from analgesic ED50 values in mice.
Deegan, P; Demuth, SM; Kinney, CM; Pong, SF, 1985
)
0.27
" Simultaneous application of Hi and 10 micrograms of diphenhydramine, pyrilamine or promethazine, apparently causing no analgesic effect from a single administration, caused a parallel shift of the dose-response curve of Hi to the right."( Analgesic effect of histamine induced by intracerebral injection into mice.
Chung, YH; Kamei, C; Miyake, H; Tasaka, K, 1984
)
0.27
" In animal experiments the compound has antiphlogistic, analgesic, antipyretic, antiasthmatic and antiaggregative activity at a dosage that causes no gastrointestinal damage."( Pharmacological profile of a new pyrrolizine derivative inhibiting the enzymes cyclo-oxygenase and 5-lipoxygenase.
Augustin, J; Dannhardt, G; Laufer, S; Tries, S, 1994
)
0.29
" Ampiroxicam itself is not observed in plasma after oral dosing to man, nor in the rat, dog, and monkey as reported here."( Ampiroxicam, an anti-inflammatory agent which is a prodrug of piroxicam.
Carty, TJ; Falkner, FC; Marfat, A; Moore, PF; Twomey, TM; Weissman, A, 1993
)
0.29
") significantly inhibited phenylquinone-evoked writhing movements in mice, but within this dose range no clear dose-response correlation was found."( Analgesic effect of TT-232, a heptapeptide somatostatin analogue, in acute pain models of the rat and the mouse and in streptozotocin-induced diabetic mechanical allodynia.
Almási, R; Bölcskei, K; Börzsei, R; Elekes, K; Helyes, Z; Kéri, G; Petho, G; Pintér, E; Szabó, A; Szolcsányi, J; Szuts, T, 2004
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Amine oxidase [flavin-containing] AHomo sapiens (human)IC50 (µMol)5.03000.00002.37899.7700AID1484646
Amine oxidase [flavin-containing] BHomo sapiens (human)IC50 (µMol)7.87000.00001.89149.5700AID1484647
Testosterone 17-beta-dehydrogenase 3Homo sapiens (human)IC50 (µMol)5.70000.00261.76469.3000AID1799665
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (19)

Processvia Protein(s)Taxonomy
biogenic amine metabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
positive regulation of signal transductionAmine oxidase [flavin-containing] AHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
response to xenobiotic stimulusAmine oxidase [flavin-containing] BHomo sapiens (human)
response to toxic substanceAmine oxidase [flavin-containing] BHomo sapiens (human)
response to aluminum ionAmine oxidase [flavin-containing] BHomo sapiens (human)
response to selenium ionAmine oxidase [flavin-containing] BHomo sapiens (human)
negative regulation of serotonin secretionAmine oxidase [flavin-containing] BHomo sapiens (human)
phenylethylamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
substantia nigra developmentAmine oxidase [flavin-containing] BHomo sapiens (human)
response to lipopolysaccharideAmine oxidase [flavin-containing] BHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to ethanolAmine oxidase [flavin-containing] BHomo sapiens (human)
positive regulation of dopamine metabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
hydrogen peroxide biosynthetic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to corticosteroneAmine oxidase [flavin-containing] BHomo sapiens (human)
androgen biosynthetic processTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
male genitalia developmentTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
testosterone biosynthetic processTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
steroid biosynthetic processTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (11)

Processvia Protein(s)Taxonomy
protein bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
electron transfer activityAmine oxidase [flavin-containing] BHomo sapiens (human)
identical protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
estradiol 17-beta-dehydrogenase [NAD(P)] activityTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
testosterone dehydrogenase [NAD(P)] activityTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
testosterone 17-beta-dehydrogenase (NADP+) activityTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
17-beta-hydroxysteroid dehydrogenase (NADP+) activityTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (9)

Processvia Protein(s)Taxonomy
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] AHomo sapiens (human)
cytosolAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial envelopeAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] BHomo sapiens (human)
dendriteAmine oxidase [flavin-containing] BHomo sapiens (human)
neuronal cell bodyAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
endoplasmic reticulumTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
endoplasmic reticulum membraneTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
intracellular membrane-bounded organelleTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
endoplasmic reticulumTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (22)

Assay IDTitleYearJournalArticle
AID213007Inactivation of thymidylate synthetase measured as kobs at a dose 3.0 pH 6.8, 30 degrees Centigrade1983Journal of medicinal chemistry, Jul, Volume: 26, Issue:7
5-p-benzoquinonyl-2'-deoxyuridine 5'-phosphate: a possible mechanism-based inhibitor of thymidylate synthetase.
AID213004Inactivation of thymidylate synthetase measured as kobs at a dose 1.0 pH 6.8, 30 degrees Centigrade1983Journal of medicinal chemistry, Jul, Volume: 26, Issue:7
5-p-benzoquinonyl-2'-deoxyuridine 5'-phosphate: a possible mechanism-based inhibitor of thymidylate synthetase.
AID1181939Inhibition of recombinant Clostridium botulinum neurotoxin serotype A light chain assessed as Kinact to KI ratio at 50 uM after 1.5 hrs by SNAPtide FRET based assay2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Benzoquinones as inhibitors of botulinum neurotoxin serotype A.
AID1484650Irreversible inhibition of recombinant human MAO-B expressed in baculovirus infected BTI insect cell microsomes assessed as residual activity using kynuramine as substrate at 4 times IC50 concentration preincubated for 15 mins with subsequent dialysis for2017European journal of medicinal chemistry, Jul-28, Volume: 135The evaluation of 1,4-benzoquinones as inhibitors of human monoamine oxidase.
AID1484654Reversible inhibition of recombinant human MAO- A expressed in baculovirus infected BTI insect cell microsomes assessed as residual activity using kynuramine as substrate at 4 times IC50 concentration preincubated for 24 hrs followed by substrate addition2017European journal of medicinal chemistry, Jul-28, Volume: 135The evaluation of 1,4-benzoquinones as inhibitors of human monoamine oxidase.
AID326467Inhibition of purified human recombinant IDO2008Journal of medicinal chemistry, Mar-27, Volume: 51, Issue:6
Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.
AID212993Substrate concentration measured for Inactivation of thymidylate synthetase at a dose 30 pH 6.8, 30 degrees Centigrade1983Journal of medicinal chemistry, Jul, Volume: 26, Issue:7
5-p-benzoquinonyl-2'-deoxyuridine 5'-phosphate: a possible mechanism-based inhibitor of thymidylate synthetase.
AID1484653Irreversible inhibition of recombinant human MAO-A expressed in baculovirus infected BTI insect cell microsomes assessed as residual activity using kynuramine as substrate at 4 times IC50 concentration preincubated for 15 mins with subsequent dialysis for2017European journal of medicinal chemistry, Jul-28, Volume: 135The evaluation of 1,4-benzoquinones as inhibitors of human monoamine oxidase.
AID1484646Inhibition of recombinant human MAO-A expressed in baculovirus infected BTI insect cell microsomes using kynuramine as substrate after 20 mins by fluorescence spectroscopy2017European journal of medicinal chemistry, Jul-28, Volume: 135The evaluation of 1,4-benzoquinones as inhibitors of human monoamine oxidase.
AID212821The rate constant in Acetonitrile and buffered aqueous acetonitrile solution, at 30 degrees C and pH 6.81986Journal of medicinal chemistry, Sep, Volume: 29, Issue:9
Thiol addition to quinones: model reactions for the inactivation of thymidylate synthase by 5-p-benzoquinonyl-2'-deoxyuridine 5'-phosphate.
AID212989Substrate concentration measured for Inactivation of thymidylate synthetase at a dose 10 pH 6.8, 30 degrees Centigrade1983Journal of medicinal chemistry, Jul, Volume: 26, Issue:7
5-p-benzoquinonyl-2'-deoxyuridine 5'-phosphate: a possible mechanism-based inhibitor of thymidylate synthetase.
AID1181944Glutathione reactivity at 1 mM in presence of 1 mM glutathione containing PBS and 1 mM EDTA buffer at pH 7.4 assessed as remaining GSH level after 30 mins by spectrophotometry by Ellman's method2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Benzoquinones as inhibitors of botulinum neurotoxin serotype A.
AID1484647Inhibition of recombinant human MAO-B expressed in baculovirus infected BTI insect cell microsomes using kynuramine as substrate after 20 mins by fluorescence spectroscopy2017European journal of medicinal chemistry, Jul-28, Volume: 135The evaluation of 1,4-benzoquinones as inhibitors of human monoamine oxidase.
AID213008Inactivation of thymidylate synthetase measured as kobs at a dose 30.0.0 pH 6.8, 30 degrees Centigrade1983Journal of medicinal chemistry, Jul, Volume: 26, Issue:7
5-p-benzoquinonyl-2'-deoxyuridine 5'-phosphate: a possible mechanism-based inhibitor of thymidylate synthetase.
AID1181943Glutathione reactivity at 1 mM in presence of 1 mM glutathione containing PBS and 1 mM EDTA buffer at pH 7.4 assessed as remaining GSH level after 10 seconds by spectrophotometry by Ellman's method2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Benzoquinones as inhibitors of botulinum neurotoxin serotype A.
AID213005Inactivation of thymidylate synthetase measured as kobs at a dose 10.0 pH 6.8, 30 degrees Centigrade1983Journal of medicinal chemistry, Jul, Volume: 26, Issue:7
5-p-benzoquinonyl-2'-deoxyuridine 5'-phosphate: a possible mechanism-based inhibitor of thymidylate synthetase.
AID1484651Irreversible inhibition of recombinant human MAO-B expressed in baculovirus infected BTI insect cell microsomes assessed as residual activity using kynuramine as substrate at 4 times IC50 concentration preincubated for 24 hrs followed by substrate additio2017European journal of medicinal chemistry, Jul-28, Volume: 135The evaluation of 1,4-benzoquinones as inhibitors of human monoamine oxidase.
AID212987Substrate concentration measured for Inactivation of thymidylate synthetase at a dose 1 pH 6.8, 30 degrees Centigrade1983Journal of medicinal chemistry, Jul, Volume: 26, Issue:7
5-p-benzoquinonyl-2'-deoxyuridine 5'-phosphate: a possible mechanism-based inhibitor of thymidylate synthetase.
AID212995Inactivation of thymidylate synthetase measured as k2 at 6.8 pH 30 degrees Celsius temp1983Journal of medicinal chemistry, Jul, Volume: 26, Issue:7
5-p-benzoquinonyl-2'-deoxyuridine 5'-phosphate: a possible mechanism-based inhibitor of thymidylate synthetase.
AID212992Substrate concentration measured for Inactivation of thymidylate synthetase at a dose 3 pH 6.8, 30 degrees Centigrade1983Journal of medicinal chemistry, Jul, Volume: 26, Issue:7
5-p-benzoquinonyl-2'-deoxyuridine 5'-phosphate: a possible mechanism-based inhibitor of thymidylate synthetase.
AID1484648Selectivity index, ratio of IC50 for recombinant human MAO-B to IC50 for recombinant human MAO-A expressed in baculovirus infected BTI insect cell microsomes2017European journal of medicinal chemistry, Jul-28, Volume: 135The evaluation of 1,4-benzoquinones as inhibitors of human monoamine oxidase.
AID1799665Inhibition Assay from Article 10.1080/14756360109162353: \\Inhibitors of human and rat testes microsomal 17beta-hydroxysteroid dehydrogenase (17beta-HSD) as potential agents for prostatic cancer.\\2001Journal of enzyme inhibition, Jan, Volume: 16, Issue:1
Inhibitors of human and rat testes microsomal 17beta-hydroxysteroid dehydrogenase (17beta-HSD) as potential agents for prostatic cancer.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (153)

TimeframeStudies, This Drug (%)All Drugs %
pre-199059 (38.56)18.7374
1990's49 (32.03)18.2507
2000's28 (18.30)29.6817
2010's16 (10.46)24.3611
2020's1 (0.65)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.21 (24.57)
Research Supply Index5.09 (2.92)
Research Growth Index4.30 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (1.24%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other159 (98.76%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]